5 questions about the surge in cases around the world – L’Express

5 questions about the surge in cases around the world

An infectious disease that can be devastating, cholera, which caused the first death in Mayotte this Wednesday, May 8, is a scourge that is on the rise in the world, primarily affecting poor countries and war zones. L’Express takes stock in five questions.

What is the health situation in Mayotte?

In the French department of Mayotte, located in the Indian Ocean, a three-year-old child died of cholera on Wednesday. As of May 6, 58 cases have been identified on the island and a vaccination campaign is underway with more than 4,000 people vaccinated to date, according to the Regional Health Agency. This outbreak comes as a major epidemic is underway in the neighboring archipelago of the Comoros, where there have been 98 deaths and more than 4,900 cases since the start of the year.

READ ALSO: Cholera, this forgotten threat which is approaching French soil

In mainland France, this disease has become very rare and mainly reported by travelers returning from infected countries or areas: there have been on average zero to two cases per year since the beginning of the 2000s, according to the Ministry of Health. We have to go back to 1986 to find traces of an outbreak in France, mainly from cases imported from North Africa, with more than thirty cases and a 10-year-old child dying after a stay in Algeria.

Where is the epidemic in the world?

As a result of climate change and the increase in conflicts, the number of cholera cases is currently exploding around the world, underlines the World Health Organization (WHO).

READ ALSO: Future pandemics: why France must rely on monoclonal antibodies

Reported cases (only a portion of proven cases) more than doubled between 2021 and 2022 to reach 473,000, then climbed further to more than 700,000 in 2023. Comoros, Democratic Republic of Congo (DRC), Ethiopia, Mozambique, Somalia, Zambia and Zimbabwe are among the most severely affected countries currently, says the WHO.

What are the symptoms ?

An acute diarrheal infection, cholera is caused by the absorption of food or water contaminated by a bacteria, the bacillus vibrio cholerae or cholera vibrio. Three-quarters of infected people express no symptoms. But when it occurs, the disease can be serious in 10 to 20% of cases, with severe diarrhea and vomiting which cause accelerated dehydration.

If left untreated, cholera is one of the most rapidly fatal infectious diseases: death can occur within one to three days. Only rapid treatment by infusion, with the administration of rehydration salts and antibiotics, can prevent death.

What links with poverty and climate change?

Haiti, Syria or the DRC: the list of recent cholera outbreaks shows how this disease is a marker of poverty, instability and armed conflicts. “There is a close link between the transmission of cholera and inadequate access to drinking water and sanitation facilities” underlines the WHO.

READ ALSO: These health cataclysms that await us: “Infections and pollution, an explosive cocktail”

Places at risk of epidemics are typically refugee camps: humanitarian crises with the displacement of populations and difficulties in accessing drinking water considerably increase the risks.

Climate change, by increasing the intensity and frequency of floods, cyclones and droughts, disrupts access to drinking water and “creates an ideal environment for the development of cholera”, according to the WHO. Recent example: cases of cholera in Mozambique increased tenfold after the passage of Cyclone Freddy which, at the start of 2023, deprived some of the inhabitants of drinking water.

What are the vaccines?

Several oral vaccines have been developed and are recommended by the WHO for areas where cholera is endemic and during epidemics.

READ ALSO: Covid: why anti-vaxxers are more prone to adverse effects

But the multiplication of outbreaks has dangerously limited stocks and forced humanitarian organizations to reduce the number of doses administered during vaccination campaigns. WHO in April gave the green light to the simplified version of a vaccine, produced by the South Korean group EuBiologics, to accelerate production and replenish global stocks of anticholera serums.

lep-life-health-03